Company & Sponsor Intelligence
Medical College of Wisconsin
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials4
Recruiting0
Completed3
Countries1
Therapeutic footprint
alzheimersautismepilepsyother_neurology
Indexed studies
NCT03513757Dexmedetomidine and Propofol for Pediatric MRI Sedation
epilepsy · United StatesPHASE4
epilepsy · United StatesPHASE4
NCT03461861Network-Level Mechanisms for Preclinical Alzheimer's Disease Development
alzheimers · United StatesPHASE2
alzheimers · United StatesPHASE2
NCT01655485Effect of a Social Script iPAD Application for Children With Autism Spectrum Disorder
autism · United StatesNA
autism · United StatesNA
NCT05343988Percutaneous Neurostimulation to Treat Paroxysmal Sympathetic Hyperactivity in Children
other_neurology · United StatesNA
other_neurology · United StatesNA
Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →